VT-EBV-N

· ViGenCell Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VT-EBV-N, covering 2022-04-29 to 2022-04-29. Get the full timeline:

Most recent: Clinical Trial Update: VT-EBV-N for Treatment of Severe in EBV Positive Extranodal NK/T Cell Lymphoma Patients [Phase 2]